Ulrich-Pur, H. (2007) “Phase II trial of pegylated liposomal doxorubicin (Caelyx™) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer”, Acta Oncologica, 46(2), pp. 208–213. doi: 10.1080/02841860600897868.